676
Views
16
CrossRef citations to date
0
Altmetric
PAPERS

Direct visualization of phase separation induced by phenothiazine-type antipsychotic drugs in model lipid membranes

, &
Pages 103-114 | Received 23 Jul 2010, Accepted 13 Sep 2010, Published online: 29 Dec 2010
 

Abstract

Lipid rafts constitute dynamic assemblies within a bilayer, engaged in, e.g., signal transduction, membrane trafficking and cell polarization. Despite wide interest in the process of domain formation in binary or ternary lipid model systems, only a limited number of papers are devoted to the influence of different additives on this process. In particular, works devoted to the role of drugs in raft formation are missing. In the present study, the influence of trifluoperazine, thioridazine and chlorpromazine on domain organization in raft-mimicking model membranes was investigated. Using giant unilamellar vesicles formed from an equimolar DOPC:sphingomyelin:cholesterol mixture, we found that phenothiazines elevated the number of domains, decreased their area and markedly increased the total length of the domain border. The impact of studied drugs on phase separation in the raft lipid mixture was also confirmed by Laurdan generalized polarization measurements. Alteration of domain organization induced by antipsychotic drugs was very likely to arise from selective accumulation of phenothiazines in interfacial regions between liquid ordered and liquid disordered domains. Interpretation of the results allowed us to demonstrate new aspects underlaying mechanisms of action of phenothiazine-type antipsychotic drugs. To the best of our knowledge, this is the first report demonstrating the influence of drugs on domain morphology directly visualized in giant unilamellar vesicles.

Declaration of interest: This work was supported by the Polish Committee for Scientific Research, funds for the Wrocław Medical University (Department of Biophysics). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.